January 06, 2016
Pharmaceutical companies Endo and Depomed told a New Jersey federal court on Wednesday that they seek to dismiss all claims and counterclaims in their dormant fight over whether painkiller Opana ER infringes three Depomed patents for extended-release drug technology.
April 18, 2013
Depomed Inc. on Wednesday sued Endo Pharmaceuticals Inc. in New Jersey federal court, accusing Endo's painkiller Opana ER of infringing three patents for extended-release drug technology.